Tolterodine once-daily in treatment of the overactive bladder: Reply by the author

By Van Kerrebroeck P.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 831-832

Elsevier

Access to resources Recommend Favorite

Once-Daily, Extended-Release Formulations of Antimuscarinic Agents in the Treatment of Overactive Bladder: A Review

By Rovner E.S.   Wein A.J.  

European Urology, Vol. 41, Iss. 1, 2002-01 ,pp. : 6-14

Elsevier

Access to resources Recommend Favorite

Tolterodine treatment augmented by simplified bladder training in Overactive Bladder (OAB) patients

By Mattiason A.   Massey D.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 133-133

Elsevier

Access to resources Recommend Favorite

A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women

By Sand Peter   Miklos John   Ritter Henry   Appell Rodney  

International Urogynecology Journal, Vol. 15, Iss. 4, 2004-08 ,pp. : 243-248

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Safety, Tolerability and Efficacy of Extended-Release Tolterodine in the Treatment of Overactive Bladder

By Kreder K.   Mayne C.   Jonas U.  

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 588-595

Elsevier

Access to resources Recommend Favorite